In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1932 News Items found
Doctor in white coat talking to a patient.
Feature
Testicular Cancer: Myths and Facts

Learn how testicular cancer is often misunderstood and why it is highly treatable.
Dr. Andrew Kobets
Meet Andrew Kobets, a Pediatric Neurosurgeon at MSK Kids

Andrew Kobets, a pediatric neurosurgeon and member of the MSK Kids team, has a passion for helping children and their families face the challenges of a cancer diagnosis.
MSK patient Anthony Valente and Dr. Alexander Drilon
FDA Approves Zidesamtinib for Lung Cancers With ROS1 Fusions

Zidesamtinib, a new drug that treats non-small cell lung cancer carrying a mutation called a ROS1 fusion, has been approved by the FDA.
MSK logo visible on sleeve of lab coat
Fueling the Next Generation of Biomedical Research

Sixteen exceptional early-career scientists are advancing groundbreaking biomedical research at MSK thanks to the generous support of MSK philanthropists. These postdoctoral researchers, selected for their innovative research proposals and scientific promise, represent the future of oncology discovery. 
An MSK researcher reviews images on a screen
MSK Research Highlights, September 14, 2026

New MSK research shows how a metabolite boosts immune cells against cancer; adds to the understanding of how colorectal cancer spreads; reveals tumor CD19 levels may predict the success of CAR T cell therapy; and finds a new targeted drug combination shows promise in early trial for small cell lung cancer.
MSK patient Joanne Ferrari-Mautino seen outdoors with her son and boyfriend.
How ROS1-Targeted Therapy Is Helping People With Advanced Lung Cancer Live Better, Longer

Learn how MSK is helping people with lung cancer driven by ROS1 fusions, thanks to continual improvements in specific targeted therapies.
Caleb Lareau
Using AI To Design Better Cancer Therapies

How MSK researchers are using artificial intelligence (AI) to design better "binders" for CAR T cell therapies.
Doctors Nancy Lee, Alan Ho, and Richard Wong are seen discussing a medical image.
New Throat Cancer Treatments Aim To Reduce Deaths and Preserve Function

Learn how MSK's world-class Head and Neck cancer specialists help people facing throat cancer, using the latest therapies and innovations.
Dr. Geoffrey Ku
FDA Approves Zanidatamab for HER2-Positive Cancers of the Stomach and Esophagus

For patients who are newly diagnosed with gastroesophageal adenocarcinoma, the most common type of stomach and esophageal cancer, the FDA has approved zanidatamab as an additional medication for those who are getting chemotherapy.
MSK radiation oncologist Nancy Lee
In the Clinic
FDA Reviewing Low-Dose Radiation To Treat HPV Throat Cancer With Fewer Side Effects

Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery.